- Medical School - Western University Canada (2004-2006)
- Residency - Lehigh Valley Health Network (2006-2009), Internal Medicine
- Fellowship - Georgetown University Hospital (2010-2012), Infectious Diseases
- Fellowship - Mayo Clinic (2012-2013), Transplant Infectious Diseases
Pearlie Chong, M.D.
- Dedman Family Scholar in Clinical Care
- Internal Medicine - Infectious Diseases and Geographic Medicine
- Infectious Complications Transplant Recipients
Dr. Pearlie Chong received her M.D. in 2006 at the Schulich School of Medicine & Dentistry at Western University in London, Ontario, Canada. After obtaining her M.D. Dr. Chong completed an Internal Medicine Residency at Lehigh Valley Health Network in Allentown, Pennsylvania, and an Infectious Diseases Fellowship at Georgetown University Medical Center. Dr. Chong developed a strong interest in Transplant Infectious Diseases while at Georgetown and went on to complete a Transplant Infectious Diseases Fellowship at Mayo Clinic, Rochester, Minnesota.
At the completion of her fellowships, Dr. Chong was recruited to the Division of Infectious Diseases at the University of North Carolina as Clinical Assistant Professor of Medicine to co-create the Immunocompromised Host Infectious Diseases Program. While at UNC, Dr. Chong improved the quality of care delivered to solid organ transplant, bone marrow transplant patients, and patients with hematologic malignancies by her active participation on the inpatient consult service and clinics. She also successfully developed protocols, was the Immunocompromised Host ID representative at the Anti-Infective Subcommittee Meeting of the UNC Pharmacy and Therapeutics Committee, and worked collaboratively with the Center for International Blood and Marrow Transplant Research (CIBMTR) Infectious Diseases Working Committee to improve the quality of data collection forms for all transplant recipients.
Dr. Chong brings to UTSW a strong background in Transplant Infectious Diseases. Her clinical practice emphasizes evidence-based, patient-centered care with a multidisciplinary approach. Dr. Chong is passionate about addressing clinical questions that arise in the day-to-day care of transplant patients and believes that advances in clinical research will help prevent and treat infectious complications in immunocompromised individuals. She is currently working on completing her Master of Science in Clinical Research through the Gillings School of Public Health at UNC.
- Transplant Infectious Diseases Special Interest Group, American Society of Bone Marrow Transplantation (ASBMT) (2014), Member
- Center for International Blood and Marrow Transplant Research (CIBMTR), Infectious Diseases Working Group (1214), Member
- Infectious Diseases Society of America (2010), Member
- Best (Trainee) Abstract Award 2014, Thoracic and Critical Care Community of Practice, American Society of Transplantation, World Transplant Congress
- ID Week Trainee Award Grant 2013, Infectious Diseases Week
- Poster of Distinction Award 2013, American Transplant Congress, Seattle, WA
- State Champion Team 2009, American College of Physicians Medical Jeopardy
- Dean's List for High Academic Achievement 2003, International Medical University, Malaysia
Norovirus in health care and implications for the immunocompromised host.
Chong PP, Atmar RL, Current opinion in infectious diseases 2019 Aug 32 4 348-355
Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018.
Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger-Isakov L, Dipchand AI, Hébert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon M, Tapiero B, Verma A, Walter JE, Allen UD, Pediatric transplantation 2019 Nov 23 7 e13571
Reply to Cheng and Chuang.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Jan
Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Sep
Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.
Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP, International journal of antimicrobial agents 2019 Sep 54 3 346-350
The gut microbiota in transplant patients.
Chong PP, Koh AY, Blood reviews 2019 Aug 100614
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
Torres HA, Chong PP, De Lima M, Friedman MS, Giralt S, Hammond SP, Kiel PJ, Masur H, McDonald GB, Wingard JR, Gambarin-Gelwan M Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Nov 21 11 1870-82
Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC Clinical therapeutics 2016 Nov 38 11 2468-2476
Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation.
Chong PP, van Duin D, Sonderup JL, Grant WJ, Kalil AC, Florescu DF Clinical transplantation 2016 Nov 30 11 1488-1493
Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.
Hauck CG, Chong PP, Miller MB, Jamieson K, Fine JP, Foster MC, Shea TC, van Duin D Pathogens & immunity 2016 Fall-Winter 1 2 234-242
Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.
Florescu DF, Sonderup JL, Grant W, Chong PP, van Duin D, Kalil AC Transplant infectious disease : an official journal of the Transplantation Society 2017 Mar
Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
Chong PP, Kennedy CC, Hathcock MA, Kremers WK, Razonable RR Clinical transplantation 2015 Apr 29 4 311-8
Diagnostic and management strategies for donor-derived infections.
Chong PP, Razonable RR Infectious disease clinics of North America 2013 Jun 27 2 253-70
- Norovirus in health care and implications for the immunocompromised host.
- Study Design and Data Analyses
- Clinical Research Related to Infections in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients
- Infectious Complications Transplant Recipients
Results: 1 Locations